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ABSTRACT
Attitudes and beliefs towards psychotropic medication were evaluated among psychiatric 
outpatients, patients seeking buprenorphine for substance abuse, and nonusers in a 
general population. The Drug Attitude Inventory scale (DAI-10) and the Beliefs about 
Medicines Questionnaire General (BMQ-G) were used to assess attitudes and beliefs of 
49 participants. The general population had a negative attitude toward psychotropic 
medication and the psychiatric groups showed positive attitudes. Compliance and 
noncompliance were not associated with attitudes or beliefs toward psychotropic 
medication. Other findings include that females had less positive attitudes and beliefs 
towards psychotropic medication than males. The current findings expand and support 
research associated with substance abuse treatment of buprenorphine and attitudes toward 
psychotropic medication among psychiatric patients and the general population.
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